Radon exposure is the second leading cause of lung cancer among nonsmokers yet testing and mitigation remain underutilized. As we mark National Radon Action Month, Evernorth remains committed to raising awareness of targeted therapies for non-small cell lung cancer and encouraging access to genomic testing to reduce risk and save lives. Learn more through the link in bio.